Jerry Carter

In the process of preclinical development, a compound or biological agent must go through the testing phases, for the following targets, which are the identification of potential targets of disease...

Recently, many scientists around the world summarized what they have learned about Omicron (an emerging variant of SARS-CoV-2) so far, as reported in Nature.Researchers from all over the world are now...

How to scale monoclonal antibody discovery under GMPDuring the event entitled "Generation of a dual-function multi-engager antibody for simultaneous targeting NK cells and tumor cells", the targeted...

The continued emergence of SARS-CoV-2 variants and breakthrough infections following vaccination underscore the need to study the effectiveness of current COVID-19 vaccines in the real world.To date...

PDX model (full name: patient-derived tumor xenograft model) is a transplanted tumor model formed by implanting patient-derived tumor tissue and primary cells into the body of immunodeficient mice. It...

Cancer has always been one of the arch nightmares among all human diseases. It is also known as the "king of all diseases" because of its complexity and incurable nature.In order to find a cure for...

Autoimmune diseases are the third most common disease category, after cancer and heart disease. It is interesting to note that 80% of patients with autoimmune diseases are women. For example, in...

Colorectal cancer (CRC) refers to cancers that begin in the tissues of the colon or rectum. After breast cancer and lung cancer, it is the commonly occurring malignant tumor. The proportion of...

In the field of tumor therapy, antibody-drug conjugate (ADC) with both targeting and strong activities has gradually become the new focus of the industry due to its excellent performance in many...

Since the outbreak of the COVID-19 epidemic, several effective vaccines have been created at breakneck speed. However, more than 40 years after Michael Gottlieb, MD, a University of Rochester...

In modern drug development, one of the hardest questions is not whether a therapy works in an early experiment, but whether those findings can translate into meaningful clinical results. Many...

Recently, Cleveland Clinic researchers formally initiated a clinical trial of a breast cancer vaccine aimed to prevent triple-negative breast cancer, which could become the first breast cancer vaccine...

Scientists first identified and recognized the importance of mRNA in 1960, and it has since been studied and explored for use in vaccines and disease therapies. But until the end of 2020, the two mRNA...